Brain metastases in HER2-positive breast cancer

被引：8
作者：
Lin, Nancy U. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Div Womens Canc, Boston, MA 02215 USA
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 03期
关键词：
NERVOUS-SYSTEM METASTASES; TRASTUZUMAB; LAPATINIB; WOMEN;
D O I：
10.1016/S1470-2045(13)70046-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 186
页数：3
相关论文
共 50 条
  • [41] Optimizing Treatment of HER2-Positive Breast Cancer
    Gradishar, William J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (5.5): : 649 - 651
  • [42] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [43] Treatment strategy for HER2-positive breast cancer
    Mukai, Hirofumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (04) : 335 - 340
  • [44] Current challenges in HER2-positive breast cancer
    Puglisi, Fabio
    Fontanella, Caterina
    Amoroso, Vito
    Bianchi, Giulia Valeria
    Bisagni, Giancarlo
    Falci, Cristina
    Fontana, Andrea
    Generali, Daniele
    Gianni, Lorenzo
    Grassadonia, Antonio
    Moscetti, Luca
    Portarena, Ilaria
    Rossi, Emanuela
    Marchetti, Paolo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 211 - 221
  • [45] HER2-positive male breast cancer: an update
    Ottini, Laura
    Capalbo, Carlo
    Rizzolo, Piera
    Silvestri, Valentina
    Bronte, Giuseppe
    Rizzo, Sergio
    Russo, Antonio
    BREAST CANCER-TARGETS AND THERAPY, 2010, 2 : 45 - 58
  • [46] Preoperative treatment of HER2-positive breast cancer
    Wysocki, Piotr J.
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (02): : 69 - 74
  • [47] Targeted Therapy in HER2-Positive Breast Cancer
    Thill, Marc
    Kraft, Clayton
    Friedrich, Michael
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (05) : 295 - 302
  • [48] Treatment strategy for HER2-positive breast cancer
    Hirofumi Mukai
    International Journal of Clinical Oncology, 2010, 15 : 335 - 340
  • [49] Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases
    Lin, Nancy U.
    Eierman, Wolfgang
    Greil, Richard
    Campone, Mario
    Kaufman, Bella
    Steplewski, Klaudia
    Lane, Stephen R.
    Zembryki, Denise
    Rubin, Stephen D.
    Winer, Eric P.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (03) : 613 - 620
  • [50] Management of metastatic HER2-positive breast cancer: present and future
    Guiu, S.
    Coudert, B.
    Favier, L.
    Arnould, L.
    Fumoleau, P.
    BULLETIN DU CANCER, 2010, 97 (03) : 365 - 383
12345